Stay updated with breaking news from Zenas yiu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Substantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy. ....
Risankizumab Long-Term Risk-Benefit Profile for Moderate to Severe Psoriasis medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Analysis of data collected from clinic reproduced psoriasis drug trial results medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.